Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

J. Michael Bostwick, MD

Dr Bostwick is professor of psychiatry at the Mayo Clinic.

Articles by J. Michael Bostwick, MD

Let’s Ask the Right Questions About Medical Aid in Dying

ByBrent Michael Kious, MD, PhD,Margaret Battin, PhD,J. Michael Bostwick, MD,Lewis M. Cohen, MD,Elizabeth Morrison MD,Thomas Strouse, MD,Stuart Youngner, MD

August 11th 2021

Some patients are intractably and maybe even irredeemably ill. What should be done for them?

A New Question in End-of-Life Ethics

ByThomas Strouse, MD,Margaret Battin, PhD,J. Michael Bostwick, MD,Lewis M. Cohen, MD,Elizabeth Morrison MD,Stuart Youngner, MD

June 11th 2021

Patients with terminal illnesses may choose to refuse treatment or even hasten their own deaths, but is that the same thing as suicide?

Latest Updated Articles

Trending on Psychiatric Times

The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law

Preliminary Report on Dangers of AI Chatbots

Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Fostering Resiliency in Mental Health Professionals: A Strengths-Based, Trauma-Informed Framework

© 2025 MJH Life Sciences^®

All rights reserved.